enVVeno Medical Corporation
NVNO
$0.9381
-$0.0308-3.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -48.66% | 27.71% | -10.40% | -13.84% | 0.72% |
| Total Depreciation and Amortization | 6.56% | 0.00% | -5.43% | -5.15% | -3.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 80.24% | -25.62% | 13.94% | 3.96% | -10.46% |
| Change in Net Operating Assets | 375.10% | -259.70% | -155.83% | 621.74% | -120.00% |
| Cash from Operations | 7.54% | 21.29% | -19.39% | -9.44% | -10.06% |
| Capital Expenditure | -- | -- | 55.56% | 35.71% | -40.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -45.65% | 147.06% | -277.43% | 56.23% | 80.57% |
| Cash from Investing | -45.74% | 147.04% | -277.75% | 56.56% | 80.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -100.00% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -175.49% | 107.32% | -204.03% | 23,437.88% | 105.05% |